{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:23:34Z","timestamp":1787027014105,"version":"build-2736575974"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T00:00:00Z","timestamp":1535587200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.00964","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T09:31:47Z","timestamp":1535621507000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Measuring Health-Related Quality of Life in Tuberous Sclerosis Complex \u2013 Psychometric Evaluation of Three Instruments in Individuals With Refractory Epilepsy"],"prefix":"10.3389","volume":"9","author":[{"given":"Petrus J.","family":"de Vries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Franz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Curatolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Nabbout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Neary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Herbst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Sully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Brohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,8,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.jval.2017.05.015","article-title":"Patient-reported outcome and observer-reported outcome assessment in rare disease clinical trials: an Ispor Coa emerging good practices task force report.","volume":"20","author":"Benjamin","year":"2017","journal-title":"Value Health"},{"key":"B2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.yebeh.2011.12.023","article-title":"Defining minimally important change in Qolie-31 scores: estimates from three placebo-controlled lacosamide trials in patients with partial-onset seizures.","volume":"23","author":"Borghs","year":"2012","journal-title":"Epilepsy Behav."},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1201\/b16139","author":"Cappelleri","year":"2013","journal-title":"Patient-Reported Outcomes: Measurement, Implementation and Interpretation."},{"key":"B4","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.yebeh.2003.11.031","article-title":"Quality of life improvement with conversion to lamotrigine monotherapy.","volume":"5","author":"Cramer","year":"2004","journal-title":"Epilepsy Behav."},{"key":"B5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1528-1157.1998.tb01278.x","article-title":"Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory.","volume":"39","author":"Cramer","year":"1998","journal-title":"Epilepsia"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1111\/j.1528-1157.1999.tb00828.x","article-title":"Development of the quality of life in epilepsy inventory for adolescents: the Qolie-Ad-48.","volume":"40","author":"Cramer","year":"1999","journal-title":"Epilepsia"},{"key":"B7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/BF02310555","article-title":"Coefficient alpha and the internal structure of tests.","volume":"16","author":"Cronbach","year":"1951","journal-title":"Psychometrika"},{"key":"B8","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","article-title":"Neurological and neuropsychiatric aspects of tuberous sclerosis complex.","volume":"14","author":"Curatolo","year":"2015","journal-title":"Lancet Neurol."},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7525-4-54","article-title":"Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change.","volume":"4","author":"de Vet","year":"2006","journal-title":"Health Qual. Life Outcomes"},{"key":"B10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2014.10.004","article-title":"Tuberous sclerosis associated neuropsychiatric disorders (Tand) and the Tand Checklist.","volume":"52","author":"de Vries","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.yebeh.2005.07.004","article-title":"I just want to be normal: a qualitative study exploring how children and adolescents view the impact of intractable epilepsy on their quality of life.","volume":"7","author":"Elliott","year":"2005","journal-title":"Epilepsy Behav."},{"key":"B12","year":"2005","journal-title":"Reflection Paper of the Regulatory Guidance for the use of Health-related Quality of Life (Hrql) Measures in the Evaluation of Medicinal Products."},{"key":"B13","first-page":"2014","year":"2011","journal-title":"Position Paper: Patients\u2019 Priorities and Needs for Rd Research"},{"key":"B14","year":"2009","journal-title":"Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (Exist-3): a phase 3, randomised, double-blind, placebo-controlled study.","volume":"388","author":"French","year":"2016","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/014662168400800306","article-title":"Procedures for assessing the validities of tests using the\u201d known-groups\u201d method.","volume":"8","author":"Hattie","year":"1984","journal-title":"Appl. Psychol. Meas."},{"key":"B17","author":"Hedges","year":"1985","journal-title":"Statistical Methods for Meta-Analysis."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex.","volume":"2","author":"Henske","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0895-4356(99)00206-1","article-title":"Methods for assessing responsiveness: a critical review and recommendations.","volume":"53","author":"Husted","year":"2000","journal-title":"J. Clin. Epidemiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1108\/AIA-12-2015-0025","article-title":"Towards an improved understanding of Tsc-associated neuropsychiatric disorders (TAND).","volume":"2","author":"Leclezio","year":"2016","journal-title":"Adv. Autism"},{"key":"B21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jval.2013.04.004","article-title":"Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the Ispor Pro good research practices for the assessment of children and adolescents task force.","volume":"16","author":"Matza","year":"2013","journal-title":"Value Health"},{"key":"B22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1059-1311(03)00080-3","article-title":"Quality of life and psychosocial development in adolescents with epilepsy: a qualitative investigation using focus group methods.","volume":"13","author":"McEwan","year":"2004","journal-title":"Seizure"},{"key":"B23","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation.","volume":"41","author":"Norman","year":"2003","journal-title":"Med. Care"},{"key":"B24","author":"Nunnally","year":"1994","journal-title":"Psychometric Theory"},{"key":"B25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","article-title":"Epidemiology of tuberous sclerosis.","volume":"615","author":"Osborne","year":"1991","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","article-title":"Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes.","volume":"61","author":"Revicki","year":"2008","journal-title":"J. Clin. Epidemiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1528-1157.2000.tb00240.x","article-title":"Validation of a new quality of life measure for children with epilepsy.","volume":"41","author":"Sabaz","year":"2000","journal-title":"Epilepsia"},{"key":"B28","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.yebeh.2003.08.012","article-title":"Validation of the quality of life in childhood epilepsy questionnaire in American epilepsy patients.","volume":"4","author":"Sabaz","year":"2003","journal-title":"Epilepsy Behav."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780199685219.001.0001","author":"Streiner","year":"2015","journal-title":"Health Measurement Scales: A Practical Guide to their Development and Use."},{"key":"B30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","article-title":"Quality criteria were proposed for measurement properties of health status questionnaires.","volume":"60","author":"Terwee","year":"2007","journal-title":"J. Clin. Epidemiol."},{"key":"B31","year":"2017","journal-title":"Tuberous Sclerosis Support Group and Discussion Community."},{"key":"B32","author":"Wechsler","year":"2006","journal-title":"Wechsler Nonverbal Scale of Ability."},{"key":"B33","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/jnnp.73.2.116","article-title":"Clinically important change in quality of life in epilepsy.","volume":"73","author":"Wiebe","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0895-4356(99)00071-2","article-title":"Further evidence supporting an Sem-based criterion for identifying meaningful intra-individual changes in health-related quality of life.","volume":"52","author":"Wyrwich","year":"1999","journal-title":"J. Clin. Epidemiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00964\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T03:23:26Z","timestamp":1571801006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00964\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,30]]},"references-count":34,"alternative-id":["10.3389\/fphar.2018.00964"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00964","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,30]]},"article-number":"964"}}